Monitoring van de stolling bij jonge ECMO patienten

CHEKid-study: Coagulation monitoring to prevent hemostatic complications in kids on extracorporeal membrane oxygenation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON20511

Enrollment

160

Registered

2018-04-12

Start date

2019-02-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ECMO Coagulation Stolling child kind

Interventions

Collecting data about all coagulation tests during the first 14 days of ECMO, including conventional tests such as APTT, PT/INR, ACT, platelets, anti-Xa level, D-dimer, antithrombin and alternative te

Eligibility

Inclusion criteria

Inclusion criteria: Children from 0 to 18 years old treated with ECMO therapy can be included in this study within 48 hours after start of ECMO and after obtained informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients without informed consent 2. Patients after 48 hours of start of ECMO

Design outcomes

Primary

Measure	Time frame
1.Bleeding complications in the first 14 days of ECMO therapy 2.Clotting complications in the first 14 days of ECMO therapy	—

Contacts

Public ContactCH Ommen, van

c.vanommen@erasmusmc.nl010 7036691

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)